1. Berlin JA, Glasser SC, Ellenberg SS. Adverse event detection in drug development: recommendations and obligations beyond phase 3. Am J Public Health. 2008;98(8):1366–71.
2. Ventola CL. Big data and pharmacovigilance: data mining for adverse drug events and interactions. Pharm Ther. 2018;43(6):340–51.
3. US Food & Drug Administration. Real world evidence. 2022. https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence. Accessed 16 May 2022.
4. Medical Affairs Professionals Society (MAPS). The application of real world evidence (RWE) in regulatory decision making: history of RWE prior to the 21st century cures act. https://medicalaffairs.org/history-of-real-world-evidence-prior-to-the-21st-century-cures-act/. Accessed 17 Oct 2022.
5. Kim HS, Lee S, Kim JH. Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records. J Korean Med Sci. 2018;33(34): e213.